Hirayama disease is a rare neurological disorder primarily affecting young males. This condition poses diagnostic challenges ...

An FDA advisory committee has voted by a huge margin that BrainStorm’s stem cell therapy for amyotrophic lateral sclerosis (ALS) – NurOwn – does not have enough data to support its approval.

If we could at the time of surgery add a drug to the surgical wound that will actually immobilize any remaining cancer cells, then they are much more targetable with conventional treatment because ...

Cell therapy is a field rife with innovation, but most of the novel therapies being developed fall into one of two basic categories: autologous cell therapies, which involve removing a patient’s ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.

SNUG01 is a first-in-class targeted gene therapy that’s designed to increase the levels of TRIM72, a protein with ...

The U.S. Food and Drug Administration approved treatment for 11 patients with the rare familial ALS caused by mutations in ...

The paralysed man was given an injection of neural stem cells to treat his spinal cord injury. Another man can now move his arms and legs following the treatment, but the two others did not show ...